-

Humana Elects Robert S. Field to Board of Directors

  • Field is the Principal and Managing Member of ηMed Capital Management LLC, an investment firm focused on U.S. healthcare services companies, primarily in the managed care industry.

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Robert S. Field has been elected as a member of the Company’s Board of Directors, effective immediately following the Company’s 2026 Annual Meeting of Stockholders.

Field is the Principal and Managing Member of ηMed Capital Management LLC, an investment firm focused on U.S. healthcare services companies, primarily in the managed care industry. He previously served as a senior analyst at Luxor Capital, a multi-strategy investment fund, where he led healthcare services investments. Earlier in his career, Field worked as an associate at McKinsey & Company, focused on corporate and business strategy and previously practiced antitrust law at Vinson & Elkins LLP.

“We are pleased to welcome Rob and are confident that the investor perspective he has developed over more than two decades as a healthcare investor will bring meaningful insight to our Board,” said Humana Chairman of the Board Kurt J. Hilzinger. “His deep expertise across investment evaluation, risk oversight, and capital allocation —along with his strong understanding of legal and regulatory dynamics in the healthcare sector — will be valuable as Humana executes on its strategy to drive profitable, sustainable growth and long-term shareholder value.”

Field’s appointment follows a comprehensive search process led by the Humana Board and informed by shareholder engagement, including helpful input from John Petry, Managing Member of Sessa Capital, as part of the Company’s ongoing commitment to Board refreshment and strong corporate governance.

About Humana

Humana is a leading U.S. healthcare company. Through our Humana insurance services, and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best health – delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large. Learn more about what we offer at Humana.com and at CenterWell.com.

Contacts

Investors:
Lisa Stoner - Humana Investor Relations; (502) 580-2652;
lstamper@humana.com

Media:
Mark Taylor - Humana Corporate Communications; (317) 753-0345;
MTaylor108@humana.com

Humana Inc.

NYSE:HUM

Release Versions

Contacts

Investors:
Lisa Stoner - Humana Investor Relations; (502) 580-2652;
lstamper@humana.com

Media:
Mark Taylor - Humana Corporate Communications; (317) 753-0345;
MTaylor108@humana.com

More News From Humana Inc.

Humana Inc. to Release First Quarter 2026 Results on April 29, 2026

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) will release its financial results for the first quarter 2026 (1Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on April 29, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026. A webcast of the 1Q26 earnings call may be accessed via Humana’s Investor Relations page at h...

Humana Completes Aggregate $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today the completion of its public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 6.625 percent of the principal amount (the “Junior Subordinated Notes Offering”). The company expects net proceeds from the Junior Subordinated Notes Offering will be approximately $986 million after deducting underwriters’ discounts and estimated offering expens...

Humana Prices $1.0 Billion Fixed-to-Fixed Rate Junior Subordinated Notes Offering

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (the “company”) (NYSE: HUM) announced today that it has priced a public offering of $1.0 billion in aggregate principal amount of fixed-to-fixed rate junior subordinated notes due 2056, at 100.000 percent of the principal amount (the “Junior Subordinated Notes Offering”). The Junior Subordinated Notes Offering is expected to close on March 9, 2026, subject to the satisfaction of customary closing conditions. The company expects net proceeds from the...
Back to Newsroom